Market closed · Next open: Monday 9:30 AM ET
Last update: Oct 9, 2026, 6:18 PM ET

AI Infrastructure

Aramark (ARMK) Stock: Why the Q3 Beat and Nexus Data-Center Ramp Sent It to a High

Aramark beat fiscal Q3 estimates and raised its full-year organic revenue outlook to 9–10% from 7–9%, crediting the launch of operations with a top global hyperscaler under its Aramark Nexus data-center platform. ARMK jumped about 10% to a fresh 52-week high while the market and its food-services peers were flat. Why a defensive caterer got repriced as an AI-services play.

By Roberto LiccardoPublished (ET)9 min readARMK
A large modern industrial catering and dining facility supporting a hyperscale data center campus at dusk, with the low server-hall buildings and power infrastructure visible on the horizon.

Summary

Before Tuesday's open on August 11, 2026, Aramark (NYSE: ARMK) reported fiscal third-quarter results (quarter ended July 3, 2026) that beat on both lines and — the part the market rewarded — raised its full-year organic revenue outlook to 9–10% from 7–9%, explicitly crediting the ramp of its new hyperscale-data-center hospitality platform, Aramark Nexus [1][2]. Revenue was $5.06 billion, up about 9%, with adjusted EPS of $0.52, up 29% versus $0.40 a year earlier [1]. The stock, which closed at $55.71 on Monday, opened at $59.95 and traded near $61.15, up about 9.8%, at 11:09 a.m. ET — brushing a fresh 52-week high of $61.33 [3][4]. With the S&P 500 and Aramark's food-services peers roughly flat on the day, this was a company-specific re-rating: a low-beta contract caterer being repriced partly as an AI-infrastructure services play.

What changed

Two things moved at once. The base business simply executed — $5.06 billion of revenue (about +9% organic), GAAP EPS of $0.36 (+34%), adjusted operating income of $261 million (+13% in constant currency), record client retention near 98% and net-new business of $1.6 billion fiscal year to date, up 51% [1]. CEO John Zillmer summed it up plainly: "The Company delivered another impressive quarter of strong top and bottom-line results" [1]. On its own that is a solid but unremarkable quarter for a mature contract caterer.

What re-rated the stock is the second thing: Aramark raised its full-year FY2026 organic revenue outlook to 9–10%, up from 7–9%, and management tied the increase directly to "commencing operations with a top global hyperscaler." Late in the third quarter, Aramark began operations at its first Texas-based site supporting a top global hyperscaler, with a second location mobilizing and more anticipated; separately it announced "a multi-year engagement with a leading AI data center colocation provider to serve workforce communities" [1][2]. The company reaffirmed its outlook for adjusted operating income growth (12–17%), adjusted EPS growth (20–25%) and a sub-3x leverage target [1].

Two-panel chart. Left: Aramark Q3 FY2026 versus a year earlier — revenue $4.63B to $5.06B (+9%), adjusted operating income $230M to $261M (+13% in constant currency), adjusted EPS $0.40 to $0.52 (+29%). Right: the raised FY2026 outlook — organic revenue growth lifted from a prior 7-9% to 9-10%, with adjusted operating income growth of +12-17% and adjusted EPS growth of +20-25% reaffirmed, new client wins of $1.6B fiscal year to date up 51%, and record retention near 98%.
A clean beat, but the guidance raise did the work: the top-line outlook went up because a top global hyperscaler came online. Source: Aramark Q3 FY2026 earnings release, August 11, 2026.

The segment split shows the breadth. FSS United States revenue was $3.496 billion (+8% organic) and FSS International was $1.562 billion (+11% organic) [2]. The one blemish is the balance sheet: leverage sat at about 3.5x against a stated goal of under 3x by fiscal year-end. Quarterly free cash flow was a slim +$8.7 million, while nine-month operating cash flow was still negative (about −$265 million) on the normal first-half seasonality — Aramark's cash generation is back-half weighted, so the Q4 print is what proves the deleveraging [1].

Why "Nexus" is the whole story

Aramark Nexus is the company's platform for delivering integrated hospitality, dining and facilities services inside hyperscale AI data centers — feeding and supporting the construction and operations workforces at campuses that increasingly sit in remote locations with thousands of workers and no nearby amenities [5]. It launched formally in April 2026 with a multi-year engagement with a top global hyperscaler; this quarter is the first time it showed up as live revenue and, more importantly, as a reason to lift guidance [1][5]. The read-through is that the same AI build-out repricing bitcoin miners and power producers has now reached the services layer — and Aramark is the scaled incumbent that can staff it.

Why it matters

Aramark is the mirror image of the trades that have dominated this year's AI-infrastructure coverage. Where Riot Platforms, Hut 8 and TeraWulf re-rated as the landlords of AI compute, Aramark is being repriced as one of its service providers — the caterer and facilities operator for the people who build and run the campuses. It is a lower-beta, cash-generative way to touch the same secular build-out, and this quarter is the first hard evidence that the theme extends past power and real estate into the workforce economy around the data center.

How the peers and sector traded the same day

The tell that this was Aramark's own news, not a sector move, is that nothing else moved. The broad market was flat — the S&P 500 slipped about 0.06% to 7,753 — and Aramark's two large-cap contract-services peers were unchanged on the session [9]:

Name (ticker)Aug 11 moveNote
ARMK — Aramark+9.8%Q3 beat + raised FY organic outlook on hyperscaler ramp [1][3]
CMPGY — Compass Group (ADR)≈ flat~$32.4; global No.1 caterer, also citing AI-data-center catering demand [10][11]
SDXAY — Sodexo (ADR)0.0%$13.01 at 9:50 a.m. ET; guiding faster growth from 2027 [12]
S&P 500 (index)−0.06%Broad market flat at ~7,753 [9]

Compass Group has made the same strategic point — its Business & Industry unit booked more than $2 billion of new business helped by "robust demand for food and support services from AI hyperscalers" [11] — which is exactly why Aramark's confirmation that the revenue is now live was worth a re-rating. The theme is industry-wide; the catalyst on August 11 was Aramark-specific.

What to watch

The guidance raise is the promise; the disclosure is the proof. The milestones that turn Nexus from a footnote into a modeled revenue line:

  • The Q4 FY2026 print — Aramark's cash generation is back-half weighted, so Q4 is where the sub-3x leverage target and the full-year adjusted-EPS growth of 20–25% either land or slip [1].
  • Nexus site count and disclosed revenue — one Texas hyperscaler site is live and a second is mobilizing; watch for a named, quantified Nexus contribution rather than a qualitative mention, and whether management starts breaking it out [1][5].
  • The path to Oppenheimer's $3–4B 2028 run-rate — that is the number underwriting the bull case; each new hyperscaler or colocation engagement is a data point for or against it [7].
  • Organic growth in the core FSS segments — International (+11%) is outrunning the US (+8%); the raised 9–10% company outlook assumes both hold while Nexus adds at the margin [2].
  • Fresh post-print analyst targets — the pre-earnings bull cluster ($63–$70) predates this quarter; watch whether the Aug 11 numbers pull the laggards up or simply confirm a stock already at consensus. Day-to-day is tracked on the ARMK stock page, and the next print will appear on our earnings calendar.

Illustrative valuation scenarios

The scenarios below are a descriptive, probability-weighted price-anchor exercise — not a forecast or a recommendation. The high end is anchored to a named, dated analyst target (Truist $70, Jul 27); the low end to the pre-run-up level and the more cautious Morgan Stanley $55. The probabilities are the author's own illustrative estimates and sum to 100%.

ScenarioPrice anchorProb.Key drivers
Bull~$7030%Nexus scales to multiple hyperscaler and colocation sites and gets disclosed as a real revenue line; core organic growth holds at 9–10%; leverage falls below 3x. The market keeps paying a growth multiple for an AI-services optionality. Anchored to Truist's $70 [13].
Base~$6245%The beat-and-raise holds, Nexus ramps roughly on the guided path but stays a modest contributor into FY2027, and the stock consolidates near consensus at ~23–24x forward. Matches the ~$61.6 average target [8].
Bear~$5225%Nexus timelines slip ("2–3 quarters away" becomes later), leverage stays above 3x, or a softer macro pressures the core FSS business; the AI-optionality premium compresses back toward a defensive-caterer multiple. Near Morgan Stanley's $55 and the pre-run-up zone [8].

Blending those (0.30 × $70 + 0.45 × $62 + 0.25 × $52) gives a probability-weighted anchor near $62, essentially on top of the ~$61 price [3]. Unlike the miner trades — where the Street's central case sat well above the stock — Aramark now trades in line with its blended fair value: the re-rating has largely happened, and further upside leans on Nexus turning into disclosed dollars rather than on the gap between price and target closing.

Why is Aramark (ARMK) stock up today?

On August 11, 2026, before the open, Aramark reported fiscal Q3 results that beat expectations — revenue $5.06 billion (+9%), adjusted EPS $0.52 (+29%) — and raised its full-year organic revenue outlook to 9–10% from 7–9%, crediting the launch of operations with a top global hyperscaler under its Aramark Nexus data-center platform [1][2]. The stock rose about 9.8% to roughly $61.15 by late morning, a fresh 52-week high, while the broad market and its food-services peers were flat [3][9].

ARMK data snapshot — August 11, 2026 (timestamped)

FigureValueAs-of / source
Prior close$55.71Mon, Aug 10, 2026 [3]
Open (Aug 11)$59.959:30 a.m. ET [3]
Primary intraday quote$61.15 (+9.76%)≈ 11:09 a.m. ET — StockAnalysis [3]
Corroborating quote$61.12 (+9.71%)This site's ARMK what-changed feed [4]
Volume vs average≈ 1.38M by 11:09 a.m. vs ~2.58M full-day avgAbove-average pace two hours in [3][6]
52-week range$35.07 – $61.33At/near the high, Aug 11 [3]
Market cap≈ $16.1BAt the intraday quote, Aug 11 [3]
ValuationP/E ≈ 42.8 trailing; ≈ 23.8 forwardAug 11 — StockAnalysis [3]
Dividend$0.48 (0.78%); ex-div Aug 19Aug 11 — StockAnalysis [3]

Each figure is valid only at its stated time; the intraday quote comes from a fast-moving session and two independent feeds (StockAnalysis and this site's own) agree to within a few cents on both price and the ~9.7% move.

The quarter at a glance

QuestionAnswer
What was reported?Fiscal Q3 2026 (quarter ended July 3, 2026): revenue $5.06B (+9%), GAAP EPS $0.36 (+34%), adjusted EPS $0.52 (+29%), AOI $261M (+13% cc) [1].
Why did guidance go up?Full-year organic revenue outlook raised to 9–10% (from 7–9%), reflecting the start of operations with a top global hyperscaler under Aramark Nexus [1][2].
What is Aramark Nexus?Aramark's platform providing integrated hospitality, dining and facilities services inside hyperscale AI data centers; first Texas site live late in Q3, a second mobilizing [1][5].
How big is Nexus today?Small — it nudged guidance at the margin. Analysts see "material" results 2–3 quarters out; Oppenheimer's $3–4B run-rate is a 2028 estimate, not a current figure [7].
What's the catch?Leverage was ~3.5x versus a sub-3x fiscal-year-end target, and the stock is now at a 52-week high, on the ~$61.6 consensus target and ~24x forward earnings [1][8].

Aramark (ARMK) stock FAQ

Why did Aramark (ARMK) stock jump on August 11, 2026?

Before the open, Aramark reported fiscal Q3 2026 results that beat expectations — revenue of $5.06 billion (up about 9%) and adjusted EPS of $0.52 (up 29%) — and raised its full-year organic revenue outlook to 9–10% from 7–9%, crediting the start of operations with a top global hyperscaler under its Aramark Nexus data-center platform. The stock rose about 9.8% to roughly $61.15, a fresh 52-week high.

What is Aramark Nexus?

Aramark Nexus is the company's platform for delivering integrated hospitality, dining and facilities services inside hyperscale AI data centers — supporting the large construction and operations workforces at remote campuses. It launched in April 2026 with a multi-year engagement with a top global hyperscaler; Aramark began operations at its first Texas-based hyperscaler site late in fiscal Q3 2026, with a second location mobilizing.

How much did Aramark raise guidance, and why?

Aramark lifted its full-year FY2026 organic revenue growth outlook to 9–10%, up from 7–9%, and management attributed the increase to commencing operations with a top global hyperscaler. It reaffirmed its outlook for adjusted operating income growth of 12–17%, adjusted EPS growth of 20–25%, and a leverage ratio target below 3x.

Is Aramark Nexus a big part of revenue yet?

No. Nexus moved the full-year guidance only at the margin this quarter. Even bullish analysts say 'material' results are two to three quarters away; Oppenheimer's estimate that Nexus could contribute a $3–4 billion revenue run-rate is a 2028 figure, not a current one. Today it is an early-stage growth option layered on a large, established contract-catering business.

What did the quarter's core numbers look like?

Revenue was $5.06 billion (about +9% organic), GAAP EPS $0.36 (+34%), adjusted EPS $0.52 (+29%), and adjusted operating income $261 million (+13% in constant currency). FSS United States grew 8% organically and FSS International 11%. Client retention hit a record near 98% and net-new business reached $1.6 billion fiscal year to date, up 51%. Leverage was about 3.5x against a sub-3x fiscal year-end target.

Is ARMK expensive after the move?

After the jump the stock sits at a 52-week high, essentially on the roughly $61.6 average analyst price target and around 23–24x forward earnings. That is a full multiple that already prices in much of the near-term Nexus optionality, so further upside leans on Nexus converting into a disclosed, quantified revenue line rather than on the stock closing a gap to target. This is descriptive analysis, not investment advice.

View all research →
An abstract visualization of a sharply rising stock chart over restaurant and dining motifs with a question-mark overlay, in warm amber and green tones, representing Chipotle's surge on an unconfirmed Starbucks takeover report.
Stock AnalysisOctober 8, 2026 · 9 min read

Chipotle (CMG) Surges ~6% on a Report Starbucks Explored a Takeover

Chipotle jumped about 6% to roughly $32.54 on October 8 — after running as high as about $33.40 — on a Financial Times report that Starbucks has explored a potential takeover of the burrito chain. The key word is explored: the report describes preliminary, exploratory interest, not a formal offer, and neither company confirmed a deal, so this is a stock moving on takeover speculation that could reverse if the idea goes no further. The speculation still landed hard — volume ran about three times normal — because a Starbucks–Chipotle combination would be enormous (nearly $50 billion in combined sales, potentially the largest restaurant deal ever if completed) and would reunite Starbucks CEO Brian Niccol with the chain he ran from 2018 to 2024. It resonated partly because Chipotle had become cheap for Chipotle: down about 19% over the past year and trading below the ~$44 average analyst target even after the pop, a high-quality, cash-generative brand at a discount is exactly the profile that draws suitors. But skepticism is warranted: Starbucks fell about 3% on the prospect of a $45-billion-plus deal that would strain its balance sheet mid-turnaround, the strategic fit between coffee and fast-casual Mexican is debatable, and exploratory interest frequently never becomes an offer. The classic M&A-speculation cross-section — target up, acquirer down, McDonald's higher — tells the story; the next hard data is Chipotle's October 28 earnings.

An abstract visualization of a rising stock chart over data-storage and server-rack motifs with an upward target ladder, in blue and teal tones, representing NetApp's rise on an analyst upgrade in an AI-storage re-rating.
Stock AnalysisOctober 7, 2026 · 10 min read

NetApp (NTAP) Rises ~3.5% as Evercore Upgrades to a Street-High $300 on AI Storage

NetApp outperformed a weaker broader market on October 7, rising about 3.5% to roughly $236.50 after Evercore ISI's Amit Daryanani upgraded the stock from In Line to Outperform and set a Street-high $300 price target, up from $210. The move was less about one call than the cluster behind it: over roughly a week, Loop Capital went to $260, TD Cowen to $250, and Goldman to $240, and Evercore has now leapfrogged them all with a rating upgrade — a sell-side re-rating of NetApp as an AI-storage beneficiary, its all-flash arrays and ONTAP software positioned for the data pipelines that feed GPU clusters (a story reinforced by its late-September deal to buy PEAK:AIO and its Novus launch, both earlier developments rather than a fresh catalyst). NetApp rose even as long-dated Treasury yields hit their highest since 2002 in a rates- and oil-driven risk-off that pressured high-multiple shares. But the stock is not cheap: up roughly 96% over the past year, it trades near 23 times forward earnings and 6 times sales for a business growing revenue in the low-double-digits, so the upgrades are betting AI lifts both growth and the multiple. And the Street is genuinely split — the published average target near $206 sits below the price, reflecting both the lag before the newest hikes propagate and real disagreement: a camp of fresh below-price targets (Wedbush's Hold at $170, plus Citi, Barclays and Bank of America in the $190–$220 range) against the bulls at $240–$300. Without an unusually heavy-volume surge, this is a sell-side re-rating; the fundamentals arrive with December 1 earnings.

An abstract visualization of a sharply rising stock chart over vaccine-vial and molecular motifs in blue and teal tones, representing Vaxcyte's surge after its 31-valent pneumococcal vaccine cleared a pivotal Phase 3 trial.
Stock AnalysisOctober 5, 2026 · 9 min read

Vaxcyte (PCVX) Surges ~35% as VAX-31 Meets All Primary Endpoints in Pivotal Phase 3 Trial

Vaxcyte surged to roughly $76 on October 5 — up about 35% after opening near $87 (about +54%) — when it reported positive topline data from OPUS-1, the pivotal adult Phase 3 trial of VAX-31, its 31-valent pneumococcal conjugate vaccine. The trial met all of its prespecified primary endpoints on immune-response and safety measures: in adults 50 and older, VAX-31 met non-inferiority on all 20 serotypes it shares with Pfizer's Prevnar 20 and 17 of the 19 it shares with Merck's Capvaxive (the two exceptions cleared only a less-stringent historical bar), and superiority on the three serotypes unique to VAX-31, with safety similar to the incumbents. It is the profile a broader, 31-valent shot needs to take share in a multi-billion-dollar adult pneumococcal market — and the market priced it as a transfer of value, with Pfizer down about 1.6% and Merck about 3.4% while the biotech index was flat. Vaxcyte is still a clinical-stage, pre-revenue company — a roughly $1 billion annual loss, no P/E, and years from revenue, with two more Phase 3 trials due in 2027 and a planned filing in 2028 — but about $2.5 billion of cash and investments gives it runway, and sell-side targets sit well above the current price (Guggenheim raised its target to $125 the same day; Mizuho and Jefferies reiterated standing Buys at $163 and $146). The stock's gap-up-then-fade captures the tension between clearly good data and the execution still ahead.